[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Veracyte Inc (VCYT)

Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Veracyte Inc 6000 SHORELINE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 USA

www.veracyte.com Employees: 755 P: 650-243-6300 F: 650-243-6388

Sector:

Medical

Description:

Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 3,424,656
Enterprise Value, $K 3,062,076
Shares Outstanding, K 80,391
Float, K 79,105
% Float 98.40%
Short Interest, K 6,674
Short Float 8.30%
Days to Cover 6.75
Short Volume Ratio 0.57
% of Insider Shareholders 1.60%

Financials:

Annual Sales, $ 517,150 K
Annual Net Income, $ 66,350 K
Last Quarter Sales, $ 150,320 K
Last Quarter Net Income, $ 25,490 K
EBIT, $ 108,020 K
EBITDA, $ 126,170 K

Growth:

1-Year Return 37.32%
3-Year Return 66.40%
5-Year Return 5.69%
5-Year Revenue Growth 340.20%
5-Year Earnings Growth 287.88%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.54 on 07/30/26
Next Earnings Date 11/03/26
Earnings Per Share ttm 1.52
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 19.35%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

VCYT Ratios

Ratio
Price/Earnings ttm 29.39
Price/Earnings forward 33.85
Price/Earnings to Growth N/A
Return-on-Equity % 9.26%
Return-on-Assets % 8.61%
Profit Margin % 12.83%
Debt/Equity 0.00
Price/Sales 6.95
Price/Cash Flow 30.00
Price/Book 2.59
Book Value/Share 17.27
Interest Coverage -1.29
60-Month Beta 1.95
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.